Tribendilol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K0744Q5ALP. European Medicines Agency schedules Tribendilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11259MIG. Tribendilol generally arises in the molecular formula C18H22N4O4. The term TRIBENDILOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) TRIBENDILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tribendilol under HS 29339990 and SITC 51577. As of Q4 2014, TRIBENDILOL remains the US FDA Preferred Term for this commodity. Tribendilol bears US NLM identifiers UMLS ID C2700071 and NCI Concept Code C76561. SMILES: O(CC(O)CNCCOC1C(OC)CCCC1)C1C2N[NH]NC2CCC1.